NEWS & EVENTS: Events

March 30-April 4, 2012 (Big Sky Resort, Big Sky, MT)

Keystone Symposia – Fibrosis: Translation of Basic Research to Human Disease and Novel Therapeutics
Mark L. Lupher, Jr., Ph.D., Promedior, Inc.
Company Presentation - PRM-151, Recombinant Human Pentraxin-2: Preclinical and Clinical Progress

December 1-3, 2011 (Marriot Magnificent Mile, Chicago, IL)

Pulmonary Fibrosis Foundation: IPF Summit 2011
Mark L. Lupher, Jr., Ph.D.,  Promedior, Inc.
Poster Presentation - The Effects of Recombinant Human Pentraxin-2, PRM-151, on Circulating Fibrocytes in Idiopathic Pulmonary Fibrosis (IPF)

November 4-8, 2011 (The Mascone Center, San Francisco, CA)

The Liver Meeting 2011, The 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Tatiana Kisseleva, M.D., University of California, San Diego
Poster Presentation - Serum amyloid P attenuates hepatic fibrosis in mice by inhibiting the activation of fibrocytes and hepatic stellate cells.

October 20, 2011 (Rosen Plaza hotel, Orlando, FL)

The Ophthalmology Innovation Summit
Dominick C. Colangelo, Promedior, Inc.
Company Presentation - A Novel Biology Platform to Treat Fibrosis and Neovascular Retinal Diseases

June 27-30, 2011 (Washington, DC)

BIO International Convention: BIO 2011
Dominick C. Colangelo, Promedior, Inc.
Panel Presentation: Financing Beyond the Lead Compound: Attracting Funding for Multiproduct Platforms

May 13-18, 2011 (Colorado Convention Center, Denver, CO)

American Thoracic Society (ATS) 2011 Annual Meeting
Jay Getsy, D.M.D., D.O., Promedior, Inc.
Poster Presentation - The Effects of Recombinant Human Pentraxin-2, (PRM-151), on Circulating Fibrocytes in Idiopathic Pulmonary Fibrosis (IPF)

May 1-5, 2011 (Fort Lauderdale/Broward County Convention Center, Fort Lauderdale, FL)

The Association for Research in Vision and Ophthalmology (ARVO) 2011 Annual Meeting
Raquel Formica, M.D., The Johns Hopkins University Wilmer Eye Institute
Poster Presentation - PRM-151, recombinant human Pentraxin-2 (PTX-2), Suppresses Choroidal (CNV)and Retinal Neovascularization (RNV)

August 1-4, 2010 (Boston University, Boston, MA)

The 11th International Workshop on Scleroderma Research
Mark L. Lupher, Jr., Ph.D., Promedior, Inc.
Company Presentation - SAP in Fibrosis

November 4-6, 2009 (The Washington, D.C. Convention Center, Wasthington, D.C.)

2009 Mid-Atlantic BIO Conference
Mark L. Lupher, Jr., Ph.D., Promedior, Inc. 
Company Presentation

January 20-25, 2009, (Keystone Symposia Center, Keystone, CO)

Keystone Symposia: Fibrosis
Mark L. Lupher, Jr., Ph.D., Promedior, Inc.
Company Presentation - Regulating fibrosis with the natural innate response modifier, SAP

December 2-3, 2008 (Pennsylvania Convention Center & Crystal Tea Room • Philadelphia, PA)

2008 Mid-Atlantic Capital Conference
Company Presentation 

November 10, 2008 (Loews Philadelphia Hotel • Philadelphia, PA)

Biotech 2008: Imagine. Collaborate. Innovate.
Company Presentation 

February 22, 2008 (Park Hyatt Hotel • Philadelphia, PA)

13th Annual Wharton Health Care Business Conference
Promedior - Harnessing the Innate Immune System for the Treatment of Fibrotic Disease 

April 22, 2008 (Hyatt Regency Hotel • Cambridge, MA)

First Annual BIO National Venture Conference
Emerging Company Presentation 

May 15, 2008 (Rice University • Houston, TX)

Rice Alliance Annual Life Science Technology Venture Forum
Life Science Company Update 

[ back to top ]